β-Alanine mediated inhibition of PTHR1suppresses the proliferation, invasion and tumorigenesis in metastatic human osteosarcoma U2OS cells

Int J Biol Macromol. 2018 May:111:1255-1263. doi: 10.1016/j.ijbiomac.2018.01.106. Epub 2018 Jan 31.

Abstract

The present study was aimed to investigate the effect of β-alanine mediated inhibition of parathyroid hormone 1 receptor (PTHR1), suppresses the proliferation, invasion, and tumorigenesis in metastatic human osteosarcoma U2OS cells. Cell survival rate was reduced 96.54, 91.23, 84.62, 76.42 and 69.72% following incubation of β-alanine at 50-250 mM respectively. Annexin-V/propidium iodide (PI) staining showed a reduced level of viable cells (71.37%) at 250 mM of β-alanine. U2OS cell proliferation, adhesion, invasion, and migration were decreased following incubation with β-alanine. Matrix metalloproteinases-2/9 (MMP-2/9) mRNA expression was reduced, whereas tissue inhibitors of metalloproteinases-1/2 (TIMP-1/2) mRNA expression was increased remarkably. The mRNA and protein of PTHR1 were reduced in the cells following incubation with β-alanine. Vacuole membrane protein 1 (Vmp1) mRNA and protein were increased in the cells following incubation with β-alanine. In tunel assay, the number of PTHR1 positive cells was 67, 34 and 17 following incubation with β-alanine at 150, 200 and 250 mM respectively. Taking all these data together, it is concluded that β-alanine mediated inhibition of PTHR1 reduced the U2OS cell proliferation, invasion, migration, and tumorigenesis. Furthermore, the results indicated that the β-alanine induced expression of PTHR1 has a positive relationship with invasion and metastasis of osteosarcoma cells.

Keywords: PTHR1; Proliferation; U2OS cells; Vmp1; β-Alanine.

MeSH terms

  • Apoptosis / drug effects
  • Carcinogenesis / drug effects
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 9 / genetics
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology
  • Neoplasm Metastasis
  • Osteosarcoma / drug therapy*
  • Osteosarcoma / genetics
  • Osteosarcoma / pathology
  • Receptor, Parathyroid Hormone, Type 1 / antagonists & inhibitors*
  • Receptor, Parathyroid Hormone, Type 1 / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / genetics
  • beta-Alanine / administration & dosage*

Substances

  • PTH1R protein, human
  • Receptor, Parathyroid Hormone, Type 1
  • Tissue Inhibitor of Metalloproteinase-1
  • beta-Alanine
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9